Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Why Shares Of Etsy Are Nearing 52-Week Lows

Etsy, Inc. (NASDAQ: ETSY) shares are trading lower by 11.4% to $67.36 amid overall market weakness after the Federal Reserve on Wednesday raised its target fed funds rate by 75 basis points to a new range of between 1.5% and 1.75%, its largest interest rate hike in 28 years.

Benzinga

Activision Blizzard's Independent Board Gives Its Officers Clean Chit Against Denial Of Harassment Claims

Activision Blizzard, Inc's (NASDAQ:ATVI) Workplace Responsibility Committee of independent directors dismissed allegations of rebuttal of gender harassment claims by senior officials as alleged by different media reports. The gaming giant acknowledged some substantiated instances of gender harassment. However, it denied awareness and tolerance of harassment by the officials. Also Read: Activision Blizzard Registers 22% Revenue…

Benzinga

Why Airbnb Stock Is Falling Today

Airbnb Inc (NASDAQ: ABNB) shares are trading lower Thursday amid overall market weakness as stocks move lower following Wednesday's Fed rate hike announcement.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Why AMD Shares Are Falling Today

Advanced Micro Devices, Inc. (NASDAQ: AMD) shares, among several companies in the broader technology and semiconductor sectors, are trading lower by 7.16% to $82.91 Thursday morning amid overall market weakness.

Benzinga

Analyst Ratings for Intellia Therapeutics

Over the past 3 months, 7 analysts have published their opinion on Intellia Therapeutics (NASDAQ:NTLA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Analyst Ratings for Outbrain

Outbrain (NASDAQ:OB) has observed the following analyst ratings within the last quarter:

Benzinga

StoneCastle Financial's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Monday marks the last chance for investors to receive the next dividend payout from StoneCastle Financial (NASDAQ:BANX).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

HEXO Deal Could Be A Big Win For Tilray, This Analyst Tells Us Why

On Wednesday HEXO Corp (NASDAQ: HEXO) reported a staggering loss of CA$152.7 million ($118 million) in the third quarter of 2022, representing a

Benzinga

Why Amazon Shares Are Getting Hammered Today

Amazon.com, Inc (NASDAQ: AMZN) shares are down amid overall market weakness, trading lower by 3.91% to $103.46. The Federal Reserve Wednesday afternoon raised its target fed funds rate by 75 basis points to a new range of between 1.5% and 1.75%, its largest interest rate hike in 28 years.

Benzinga

What's Going On With Microsoft Shares Falling Today?

Microsoft Corporation (NASDAQ: MSFT) shares are getting hit Thursday morning amid overall market weakness, trading lower by 2.60% to $245.22.

Benzinga

Why Apple Shares Are Diving Today

Apple Inc (NASDAQ: AAPL) shares are trading lower by 3.19% to $131.11 Thursday morning amid overall market weakness. The Federal Reserve Wednesday afternoon raised its target fed funds rate by 75 basis points to a new range of between 1.5% and 1.75%, its largest interest rate hike in 28 years.

Benzinga

Why Tesla Stock Is Sliding Today

Tesla Inc (NASDAQ: TSLA) shares are trading lower Thursday after the company raised the prices of its vehicle models in the United States. The price hikes come as raw material costs surge amid global supply-chain disruptions.

Benzinga

Amazon's 2022 Prime Day Is Back: Here's The Schedule And What You Need To Know

Amazon.com Inc.'s (NASDAQ: AMZN) annual Prime Day shopping event is slated to return in July.

Benzinga

Expert Ratings for Diversey Hldgs

Analysts have provided the following ratings for Diversey Hldgs (NASDAQ:DSEY) within the last quarter:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022

Upgrades

Benzinga

Petco Eyes Small Towns & Rural Communities - Check Out The New Location

Petco Health And Wellness Company Inc (NASDAQ:WOOF) has launched a new community-driven test concept to serve the wellness needs of pets and farm animals in small towns and rural communities. The company will open its first location under the concept on June 17 in Floresville, Texas. Related: Here's Why Needham Is Bullish On This Pet…

Benzinga

Here's How Much $1000 Invested In ON Semiconductor 5 Years Ago Would Be Worth Today

ON Semiconductor (NASDAQ:ON) has outperformed the market over the past 5 years by 21.25% on an annualized basis producing an average annual return of 29.98%. Currently, ON Semiconductor has a market capitalization of $24.31 billion.

Benzinga

The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK

Here's a roundup of top developments in the biotech space over the last 24 hours:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Looking Into OptiNose's Return On Capital Employed

Benzinga Pro data, OptiNose (NASDAQ:OPTN) reported Q1 sales of $14.76 million. Earnings fell to a loss of $25.33 million, resulting in a 62.14% decrease from last quarter.

Benzinga

Helius Medical Tech Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Helius Medical Tech (NASDAQ:HSDT) reported Q1 sales of $190.00 thousand. Earnings fell to a loss of $4.35 million, resulting in a 5.95% decrease from last quarter.

Benzinga

Looking Into Marqeta's Return On Capital Employed

Benzinga Pro data, Marqeta (NASDAQ:MQ) reported Q1 sales of $166.10 million. Earnings fell to a loss of $60.60 million, resulting in a 64.64% decrease from last quarter.

Benzinga

Looking Into Integral Ad Science's Return On Capital Employed

Pulled from Benzinga Pro data, Integral Ad Science (NASDAQ:IAS) posted Q1 earnings of $1.16 million, an increase from Q4 of 124.04%. Sales dropped to $89.24 million, a 12.91% decrease between quarters.

Benzinga

Looking Into ACV Auctions's Return On Invested Capital

ACV Auctions (NASDAQ:ACVA) brought in sales totaling $103.06 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 12.1%, resulting in a loss of $29.50 million.

Benzinga

Yield10 Bioscience Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Yield10 Bioscience (NASDAQ:YTEN) reported Q1 sales of $149.00 thousand. Earnings fell to a loss of $3.33 million, resulting in a 11.78% decrease from last quarter.

Benzinga

Looking Into ADMA Biologics's Return On Capital Employed

Benzinga Pro data, ADMA Biologics (NASDAQ:ADMA) reported Q1 sales of $29.10 million. Earnings fell to a loss of $25.01 million, resulting in a 50.2% decrease from last quarter.

1 … 425 426 427 428

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.